CANbridge Pharmaceuticals Inc.

CANbridge Pharmaceuticals Inc.verified

1228.HK

Price:

$2.37

Market Cap:

$914.49M

CANbridge Pharmaceuticals Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide. The company offers Hunterase, an enzyme replacement therapy for the treatment of Hunter syndrome; NERLYNX (Neratinlib), a potent irreversible tyrosine kinase inhibitor for HER2-positive breast cancer; and Caphosol Mouth Rinse for temporary and persistent dryness of the mouth and throat. It also engages in the development of CAN008, an artificially engineered antibody-like fully human fusion protein for the treatment of glioblastoma multiforme; CAN108, an orally absorbed reversible inhibitor of the ileal bil...[Read more]

Industry

Biotechnology

IPO Date

2021-12-10

Stock Exchange

HKSE

Ticker

1228.HK

The Current Ratio as of December 2025 (TTM) for CANbridge Pharmaceuticals Inc. (1228.HK) is 0.09

According to CANbridge Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.09. This represents a change of -4.49% compared to the average of 0.09 of the last 4 quarters.

CANbridge Pharmaceuticals Inc. (1228.HK) Historical Current Ratio (quarterly & annually)

How has 1228.HK Current Ratio performed in the past?

The mean historical Current Ratio of CANbridge Pharmaceuticals Inc. over the last ten years is 1.90. The current 0.09 Current Ratio has changed 351.97% with respect to the historical average. Over the past ten years (40 quarters), 1228.HK's Current Ratio was at its highest in in the June 2021 quarter at 4.76. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

1.90

Median

1.34

Minimum

0.09

Maximum

4.37

CANbridge Pharmaceuticals Inc. (1228.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of CANbridge Pharmaceuticals Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 317.50%

Maximum Annual Current Ratio = 4.37

Minimum Annual Increase = -85.32%

Minimum Annual Current Ratio = 0.09

Quarterly (TTM)
Annual
YearCurrent RatioChange
20240.09-85.32%
20230.64-64.77%
20221.82-58.43%
20214.3720.79%
20203.62317.50%

CANbridge Pharmaceuticals Inc. (1228.HK) Average Current Ratio

How has 1228.HK Current Ratio performed in the past?

The current Current Ratio of CANbridge Pharmaceuticals Inc. (1228.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0.85

5-year avg

2.11

10-year avg

1.90

CANbridge Pharmaceuticals Inc. (1228.HK) Current Ratio vs. Peers

How is 1228.HK’s Current Ratio compared to its peers?

CANbridge Pharmaceuticals Inc.’s Current Ratio is less than Kintor Pharmaceutical Limited (0.44), less than Uni-Bio Science Group Limited (3.40), less than Sirnaomics Ltd. (0.41), less than China Biotech Services Holdings Limited (0.18), less than ClouDr Group Limited (1.21), less than Wenzhou Kangning Hospital Co., Ltd. (1.37), less than Hospital Corporation of China Limited (1.53), less than Transcenta Holding Limited (0.49), less than Beijing Biostar Pharms Co Ltd (0), less than Suzhou Basecare Medical Corporation Limited (4.36),

Build a custom stock screener for CANbridge Pharmaceuticals Inc. (1228.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CANbridge Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CANbridge Pharmaceuticals Inc. (1228.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CANbridge Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is CANbridge Pharmaceuticals Inc.'s Current Ratio?

How is the Current Ratio calculated for CANbridge Pharmaceuticals Inc. (1228.HK)?

What is the highest Current Ratio for CANbridge Pharmaceuticals Inc. (1228.HK)?

What is the 3-year average Current Ratio for CANbridge Pharmaceuticals Inc. (1228.HK)?

What is the 5-year average Current Ratio for CANbridge Pharmaceuticals Inc. (1228.HK)?

How does the current Current Ratio for CANbridge Pharmaceuticals Inc. (1228.HK) compare to its historical average?